PI3K and negative regulation of TLR signaling

被引:536
作者
Fukao, T [1 ]
Koyasu, S [1 ]
机构
[1] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan
基金
日本学术振兴会;
关键词
D O I
10.1016/S1471-4906(03)00139-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Excessive immune responses are detrimental to the host and negative feedback regulation is crucial for the maintenance of immune-system integrity. Recent studies have shown that phosphoinositide 3-kinase (PI3K) is an endogenous suppressor of interleukin-12 (IL-12) production triggered by Toll-like receptor (TLR) signaling and limits excessive Th1 polarization. Unlike IRAK-M (IL-1 receptor-associated kinase-M) and SOCS-1 (suppressor of cytokine signaling-1) that are induced by TLR signaling and function during the second or continuous exposure to stimulation, PI3K functions at the early phase of TLR signaling and modulates the magnitude of the primary activation. Thus, PI3K, IRAK-M and SOCS-1 have unique roles in the gate-keeping system, preventing excessive innate immune responses.
引用
收藏
页码:358 / 363
页数:6
相关论文
共 47 条
  • [1] Toll-like receptor 2-mediated NF-κB activation requires a RacI-dependent pathway
    Arbibe, L
    Mira, JP
    Teusch, N
    Kline, L
    Guha, M
    Mackman, N
    Godowski, PJ
    Ulevitch, RJ
    Knaus, UG
    [J]. NATURE IMMUNOLOGY, 2000, 1 (06) : 533 - 540
  • [2] A novel function of phosphorothioate oligodeoxynucleotides as chemoattractants for primary macrophages
    Baek, KH
    Ha, SJ
    Sung, YC
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (05) : 2847 - 2854
  • [3] Inhibition of phosphatidyl inositol-3'-kinase prevents induction of endotoxin tolerance in vitro
    Bowling, WM
    Flye, MW
    Qiu, YY
    Callery, MP
    [J]. JOURNAL OF SURGICAL RESEARCH, 1996, 63 (01) : 287 - 292
  • [4] A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation
    Clayton, E
    Bardi, G
    Bell, SE
    Chantry, D
    Downes, CP
    Gray, A
    Humphries, LA
    Rawlings, D
    Reynolds, H
    Vigorito, E
    Turner, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) : 753 - 763
  • [5] Díaz-Guerra MJM, 1999, J IMMUNOL, V162, P6184
  • [6] Dendritic cells in cancer immunotherapy
    Fong, L
    Engleman, EG
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 245 - 273
  • [7] Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice
    Fukao, T
    Yamada, T
    Tanabe, M
    Terauchi, Y
    Ota, T
    Takayama, T
    Asano, T
    Takeuchi, T
    Kadowaki, T
    Hata, J
    Koyasu, S
    [J]. NATURE IMMUNOLOGY, 2002, 3 (03) : 295 - 304
  • [8] PI3K-mediated negative feedback regulation of IL-12 production in DCs
    Fukao, T
    Tanabe, M
    Terauchi, Y
    Ota, T
    Matsuda, S
    Asano, T
    Kadowaki, T
    Takeuchi, T
    Koyasu, S
    [J]. NATURE IMMUNOLOGY, 2002, 3 (09) : 875 - 881
  • [9] The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
    Gately, MK
    Renzetti, LM
    Magram, J
    Stern, AS
    Adorini, L
    Gubler, U
    Presky, DH
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 : 495 - 521
  • [10] Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells
    Gratton, JP
    Morales-Ruiz, M
    Kureishi, Y
    Fulton, D
    Walsh, K
    Sessa, WC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) : 30359 - 30365